Dr. Jerry A. Molitor, MD

Dr. Molitor practices at M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview.

Dr. Molitor's NPI, 1235147331, was assigned on August 4, 2006. Dr. Molitor graduated from Carver College of Medicine in 1993. Dr. Molitor's Washington license number on file is MD00035031.

Dr. Molitor's primary practice is M Health Fairview University of Minnesota Medical Center, at 2450 Riverside Avenue, Minneapolis, MN 55454 in Hennepin County. The practice phone is (612) 624-1765.

Dr. Molitor's primary practice is M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview. Dr. Molitor is also affiliated with M Health Fairview Southdale Hospital. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Molitor to 2 more hospitals, 8 medical groups, 4 group practices and clinics and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Molitor practices, 9 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Molitor's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Molitor is board certified in rheumatology by the American Board of Internal Medicine. Dmand AI has Dr. Molitor's licenses on file in 2 states: Washington and Minnesota.

Dmand AI lists arthritis, lupus, muscle disease and rheumatoid arthritis among the conditions Dr. Molitor treats.

CMS data shows 117 Medicare services from Dr. Molitor across 3 procedure codes in 2024, for 55 Medicare patients. Medicare paid $5,644 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 55 Medicare patients who saw Dr. Molitor in 2024. The largest group is under 65, with 21 patients. 65% of them have arthritis, and 53% have high cholesterol. Their average risk score is 2.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Molitor's median patient age at 64, with 56% women.

In 2024, Dr. Molitor wrote 785 Medicare Part D claims for 105 patients. 91% of them were for generic drugs. CMS names the drug for 644 of them, across 20 drugs with 11 or more claims each, at $91,832 in total drug cost. In 2023, CMS named 776 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Molitor for performance year 2024, reported as part of a group. Dr. Molitor accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 40 papers to Dr. Molitor, published from 2007 to 2025. 2013 was the busiest year, with 3. The most frequent topics are Scleroderma, Systemic, Immunosuppressive Agents and Double-Blind Method. Dr. Molitor has published most often in Arthritis Rheum. Dr. Molitor's most frequent co-authors are Maureen D. Mayes, MD, Laura Kathleen Hummers, MD and Daniel E. Furst, MD.

Dmand AI links Dr. Molitor to 9 clinical trials, 5 of them phase 2 studies. Conditions studied include Scleroderma, Systemic, Scleroderma, Diffuse and Arthritis, Rheumatoid. National Institute of Allergy and Infectious Diseases (NIAID) sponsors the most, 3.

CMS Open Payments shows 37 general payments to Dr. Molitor from 5 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 80% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $15,603.

Dmand AI lists 4 awards for Dr. Molitor, most recently Regional Top Doctor in 2014.

Dr. Molitor graduated from Carver College of Medicine in 1993.

Dr. Molitor is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.